Shots: Merck to acquire Antelliq, in all stock transaction with its technology and pay 1.3B as debt for Antelliq. Antelliq to receive $2.3B in cash as total deal value The focus of the acquisition […]readmore
Tags : Merck
Shots: Instituto Butantan to receive $26M upfront, $75M milestones and royalties on sales from Merck. Merck to get clinical data and learnings (utilized for its TV003, dengue vaccine) from Instituto’s development programs to […]readmore
Shots: Merck to get rights for Cyclica’s cloud-based in-silico proteome screening AI platform, Ligand Express to screen small molecule for determining polypharmacological profiles The focus of agreement is to discover […]readmore
Shots: The approval is based on the results of P-III DRIVE-AHEAD and DRIVE-FORWARD trial assessing Delstrigo vs efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) & Pifeltro vs darunavir + ritonavir (DRV+r) […]readmore
Shots: The P-III KEYNOTE-181 study involves assessing of Keytruda monothx vs CT in 600 patients in ratio (1:1) receiving (Keytruda 200 mg FD q3w) or IV CT (docetaxel /paclitaxel/ irinotecan) […]readmore
Shots: The BLA filling is in response to the Breakthrough Therapy designation granted in 2016 to V920, taken alone or in combination to treat serious or life-threatening disease or condition […]readmore
Shots: The agreement involves assessing of FLXBio’s FLX475 candidate with Merck’s Keytruda (pembrolizumab) in the ongoing P-I/II as an anti-PD-1 therapy in patients with multiple types of cancer The study will […]readmore
Shots: The P-III SOLO-1 Trial includes assessing of Lynparza (olaparib) (300mg bid) vs PBO in 391 patients in ratio (2:1) with newly-diagnosed, BRCA1/2 mutation who were in CR or PR […]readmore
Shots: The termination of 2014 deal with Samsung, is the result of Lusduna Nexvue’s sales and production costs. Samsung receives $155M as total termination cost including investment and interest on […]readmore
Shots: The approval is based on a study assessing Gardasil 9 in 13,000 patients (age 27- 45 yrs) for the prevention of certain cancers and diseases caused by the nine […]readmore